✦ LIBER ✦

Low-Dose Intratympanic Gentamicin and the Treatment of Meniere's Disease: Preliminary Results

✍ Scribed by Colin L. W. Driscoll; Jan L. Kasperbauer; George W. Facer; Stephen G. Harner; Charles W. Beatty

Book ID: 110079272
Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 593 KB
Volume: 107
Category: Article
ISSN: 0023-852X
DOI: 10.1097/00005537-199701000-00017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intratympanic Gentamicin for Treatment o

Intratympanic Gentamicin for Treatment of Intractable Meniere's Disease: A Preliminary Report

✍ Steven D. Rauch; John G. Oas 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 775 KB

Intratympanic Gentamicin for the Treatme

Intratympanic Gentamicin for the Treatment of Unilateral Meniere's Disease

✍ Daniel M. Kaplan; Julian M. Nedzelski; Joseph M. Chen; David B. Shipp 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Treatment of Ménière's Disease by Low-Do

Treatment of Ménière's Disease by Low-Dosage Intratympanic Gentamicin Application: Effect on Otolith Function

✍ Kai Helling; Uwe Schönfeld; Andrew H. Clarke 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

Long-Term Disability of Class A Patients

Long-Term Disability of Class A Patients With Ménière's Disease After Treatment With Intratympanic Gentamicin

✍ Maria Soledad Boleas-Aguirre; Noelia Sánchez-Ferrandiz; Francisco Guillén-Grima; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 1020 KB

Preliminary results of a new delivery sy

Preliminary results of a new delivery system for gentamicin to the inner ear in patients with Meniere’s disease

✍ J. Thomsen; Samih Charabi; Mirko Tos 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 54 KB

Treatment of the symptoms of Huntington'

Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine

✍ Livia Brusa; Antonio Orlacchio; Vincenzo Moschella; Cesare Iani; Giorgio Bernard 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB

## Abstract Aripiprazole (AP), a dopamine (DA) D~2~ receptor partial agonist, has recently been used to reduce schizophrenic symptoms, while tetrabenazine (TBZ), a DA depletor, has been used to treat hyperkinesias in Huntington's disease (HD). The aim of this study is to define the role of AP on ch